These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 10804045

  • 1. Bupropion: a review of its use in the management of smoking cessation.
    Holm KJ, Spencer CM.
    Drugs; 2000 Apr; 59(4):1007-24. PubMed ID: 10804045
    [Abstract] [Full Text] [Related]

  • 2. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
    Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB.
    N Engl J Med; 1999 Mar 04; 340(9):685-91. PubMed ID: 10053177
    [Abstract] [Full Text] [Related]

  • 3. Review of bupropion for smoking cessation.
    Richmond R, Zwar N.
    Drug Alcohol Rev; 2003 Jun 04; 22(2):203-20. PubMed ID: 12850907
    [Abstract] [Full Text] [Related]

  • 4. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.
    J Clin Psychopharmacol; 2007 Aug 04; 27(4):380-6. PubMed ID: 17632223
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A bupropion smoking cessation clinical trial for cancer patients.
    Schnoll RA, Martinez E, Tatum KL, Weber DM, Kuzla N, Glass M, Ridge JA, Langer C, Miyamoto C, Wileyto EP, Leone F.
    Cancer Causes Control; 2010 Jun 04; 21(6):811-20. PubMed ID: 20087643
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo.
    Jamerson BD, Nides M, Jorenby DE, Donahue R, Garrett P, Johnston JA, Fiore MC, Rennard SI, Leischow SJ.
    Clin Ther; 2001 May 04; 23(5):744-52. PubMed ID: 11394732
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Varenicline in the management of smoking cessation: a single technology appraisal.
    Hind D, Tappenden P, Peters J, Kenjegalieva K.
    Health Technol Assess; 2009 Sep 04; 13 Suppl 2():9-13. PubMed ID: 19804684
    [Abstract] [Full Text] [Related]

  • 18. [Bupropion SR for weaning from smoking in relapsed smokers: results of an open multicentre trial in Germany].
    Bergmann L, Warncke W, Herschel M.
    Pneumologie; 2004 Mar 04; 58(3):140-6. PubMed ID: 15007784
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease.
    Wagena EJ, Zeegers MP, van Schayck CP, Wouters EF.
    Drug Saf; 2003 Mar 04; 26(6):381-403. PubMed ID: 12688831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.